Hasil Pencarian :: Kembali

Ditemukan 9063 dokumen yang sesuai dengan query ::  Simpan CSV
cover
John L. Fiedler, Tesfaye Chuko
HPP Vol.23, No.4
[s.l.] : [s.n.] : 2008
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Yundri Martiraz; Pembimbing: Ede Surya Darmawan; Penguji: Amal Chalik Sjaaf, Wachyu Sulistiadi, Frizar Irmansyah, Chairulsjah
Abstrak:
Dengan kemajuan dalam bidang kedokteran yang terus menerus melakukan peningkatan perbaikan layanan demi kepuasan dan keselamatan pasien yang lebih baik. ERACS (Enhanced Recovery After Cesarean Section) merupakan suatu kemajuan dalam layanan kedokteran terutama dalam bidang obstetric, dimana pendekatan multimodal dalam persiapan pre operasi, intra operasi, dan juga pasca operasi. ERACS merupakan kolaborasi multidisplin yang sangat menentukan keberhasilan luaran dari ERACS, kolaborasi anatar dokter spesialis obgyn, dokter spesialis anastesi, perawat/bidan, dan juga pasien itu sendiri. ERACS juga telah dilaksakan di RSIA Kemang Medical Care sejak November 2021 dan masih menjadi pilihan layanan untuk pasien yang akan melahirkan secara operasi terencana/elektif sampai dengan saat ini. Untuk itu dalam upaya untuk menjamin mutu pelayanan di RSIA Kemang Medical Care, maka perlu untuk mengukur efektivitas (length of stay, nyeri, dan biaya) dari penerapan protocol ERACS di RSIA Kemang Medical Care tahun 2022. Penelitian ini menggunakan pendekatan studi kuantitatif cross sectional. Dimana data yang diambil merupakan data sekunder untuk melihat kepatuhan penerapan protocol ERACS yang dilihat berdasarkan daftar tilik ERACS RSIA Kemang Medical Care. Selain itu juga melihat kepatuhan masing-masing tenaga kesehatan yang terlibat begitu juga dengan kepatuhan pasien yang menjalankan proyokol ERACS. Wawancara dilakukan kepada beberapa pihak manajemen sebagai pemangku kebijakan untuk memperkuat hasil penelitian. Berdasarkan hasil analisis statistik, dinyatakan bahwa terdapat hubungan yang signifikan (p value 0,04) antara kepatuhan penerapan protocol ERACS terhadap efektivitas ERACS di RSIA Kemang Medical Care. Dimana setiap kepatuhan penerapan protocol ERACS akan berpengaruh sebesar 8 kali terhadap efektivitas ERACS di RSIA Kemang Medical Care pada tahun 2022.

With advances in the medical field, we are continuously improving services for better patient satisfaction and safety. ERACS (Enhanced Recovery After Cesarean Section) is an advancement in medical services, especially in the field of obstetrics, where there is a multimodal approach in pre-operative, intra-operative and also post-operative preparation. ERACS is a multidisciplinary collaboration that really determines the success of ERACS outcomes, collaboration between ob-gyn specialists, anesthesiologists, nurses/midwives, and also the patients themselves. ERACS has also been carried out at RSIA Kemang Medical Care since November 2021 and is still the service of choice for patients who are going to give birth via planned/elective surgery until now. For this reason, in an effort to guarantee the quality of service at RSIA Kemang Medical Care, it is necessary to measure the effectiveness (length of stay, pain and costs) of implementing the ERACS protocol at RSIA Kemang Medical Care in 2022. This research uses a quantitative cross sectional study approach. Where the data taken is secondary data to see compliance with the implementation of the ERACS protocol which is seen based on the RSIA Kemang Medical Care ERACS checklist. Apart from that, it also looks at the compliance of each health worker involved as well as the compliance of patients who carry out the ERACS procedure. Interviews were conducted with several management parties as policy makers to strengthen the research results. Based on the results of statistical analysis, it was stated that there was a significant relationship (p value 0.04) between compliance with the implementation of the ERACS protocol and the effectiveness of ERACS at RSIA Kemang Medical Care. Where every compliance with the implementation of the ERACS protocol will have an impact of 8 times on the effectiveness of ERACS at RSIA Kemang Medical Care in 2022.
 
Read More
B-2433
Depok : FKM-UI, 2024
S2 - Tesis   Pusat Informasi Kesehatan Masyarakat
cover
Environmental Health Perspectives ( EHP ), Vol.119, No.4, April. 2011, hal. 579-584
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Sharad D. Lyngar, Kirti Lynger, Vikram Gupta
JHPN Vol.27, No.2
[s.l.] : [s.n.] : 2009
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
by Ascobat Gani, Mardiati Najib and Mary A. Wangsaharja
362.1041734598 Gan i (RS)
Jakarta : Depkes; Bappenas, 1998
Reserved (pinjaman 1 hari)   Pusat Informasi Kesehatan Masyarakat
cover
Kranti S. Vora ... [et al]
JHPN Vol.27, No.2
[s.l.] : [s.n.] : 2009
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Jacob J. Feldman
658.385 FEL d
Chicago : Aldine, 1986
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
Dileep V. Mavalankar ... [et al]
JHPN Vol.27, No.2
[s.l.] : [s.n.] : 2009
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Public Health, Vol.122, No.8, Augt. 2008, hal. 767-770. ( ket. ada di bendel 2008 ( No.7-12)
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Workshop on evidence for health policy: burden of disease, Cost-Effectiveness, and health systems (Daftar isi: 1.Expanding the WHO tuberculosis control strategy: rethinking the role active case-finding, C.J.L. Murray; 2. Modeling the impact of global tuberculosis control strategies, ChristopherJ.L. Murray; 3. The decision rules of cost-effectiveness analysis, Goran Karlsson; 4. On the decision relus of cost-effectiveness analysis, Magnus Johannesson; 5. Cost-effectiveness and capital costs, Goran k; 6. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations, Andreas Laupacis; 7. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 8. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application, A. Griffiths; 9. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, Frank A. Sloan; 10. Cost-benefit analysis (CBA); 11. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature, Karen B; 12. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution?, Julie Ratcliffe; 13. Is there a role for benefit-cost analysis in environmental, health, and safety regulation ?, Kenneth J. Arrow; 14. Reasons and persons, Derek Parfit; 15. Qalys and ethics: a health economist's perspective, Alan Williams; 16. Double jeopardy and the use of QALYs in health care allocation, Peter Singer; 17. Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to harris, John McKie; 18. The value of DALY life: problems with ethics and validity of disability adjusted life years, Erik Nord; 19. Public preferences for the allocation of donor liver grafts for transplantation, Julie Ratclife; 20. Distributing scarce livers: the moral reasoning of the general public, Peter A. Ubel; 21. Recognizing bedside rationing: clear cases and tough calls, Peter A. Ubel; 22. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Mohammad A. Chaudhary; 23. Reflecting uncertainty in cost-effectiveness analysis, W.G. Manning; 24. Hanling uncertanty in economic evaluation, Andrew Briggs; 25. Probabilistic sensitivity analysis in cost-effectiveness: an application from a study of vaccination against pneumococcal bacteremia in the elderly, William Whang; 26. Estimating uncertainty ranges for cost by the bootstrap procedure combined with probabilistic sensitivity analysis, Joanne Lord; 27. Uncertaintyin the economic evaluation of health care technologies: the role of sensitivity analysis, Andrew Briggs; 28. Building uncertainty into cost-effectiveness rankings portofolio risk-return tradeoffs and implications for decision rules, Bernie J. O'Brien; 29. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania, Eric De Jonghe; 30. Linking measures of health gain to explicit priority setting by an area health service in Australia, David A Cromwell; 31. Using discrete choice modelling in priority setting: an application to clinical service developments, Shelley Farrar; 32. Cost-effectiveness analysis and policy choices: investing in health systems, C.J.L. Murray; 33. A cost-effectiveness model for allocating health sector resources, Christopher Murray; 34. Disease control priorities in developing countries: an overview, Dean T. Jamison; 35. Oregon's medicaid ranking and cost-effectiveness: is there any relationship ?, Tammy O. Tengs; 36. Five-hundred life-saving interventions and their cost-effectiveness, Tammy O. Tengs; 37. Prioritising health services in an era of limits: the Oregon experience, John A Kitzhaber; 38. Priority setting: lessons from Oregon, Jennifer Dixon; 39. Oregon's methods: did cost-effectiveness analysis fail?; 40.
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
:: Pengguna : Pusat Informasi Kesehatan Masyarakat
Library Automation and Digital Archive